Abdulkerim Yıldız

12PUBLICATIONS
27CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursNon-Newtonian fluid flows (incl. rheology)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 14, 2026
The impact of body mass index on treatment response to high-dose dexamethasone in adult primary immune thrombocytopenia patients: A two-center retrospective study.

Abdulkerim Yıldız, Rafiye Çiftçiler, Samet Yaman

|Sep 02, 2024
Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study.

Rafiye Çiftçiler, Cem Selim, Melda Cömert

|Aug 28, 2024
Non-hemolytic acute transfusion reactions: the impact of patient and blood product characteristics.

Abdulkerim Yıldız, Gökhan Evren, Bilge Zihar

|Oct 25, 2023
Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study

Emine Merve Savaş, Seda Yılmaz, Ayşe Asena Başer Dikyar

|Aug 23, 2021
Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect.

Mesut Tığlıoğlu, Pınar Tığlıoğlu, Abdulkerim Yıldız

|May 20, 2021
Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis.

Mesut Tığlıoğlu, Murat Albayrak, Servihan Doğan

Pageof 2

Frequent Collaborators

5 joint publications

Hacer Berna Öztürk

3 joint publications

Pınar Tığlıoğlu

2 joint publications

Senem Maral

2 joint publications

Buğra Sağlam